CAMBRIDGE, Mass.--(BUSINESS WIRE)--Paragonix Technologies, the leading hypothermic donor organ preservation provider, announced the first-in-human clinical use of the investigational NRP-DCD Method by ...
Please provide your email address to receive an email when new articles are posted on . Only super rapid recovery LT recipients experienced ischemic cholangiopathy and primary nonfunction. Early ...
Please provide your email address to receive an email when new articles are posted on . The use of normothermic regional perfusion could injure donor lungs meant for transplantation. More research is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results